Treatment interruption and discontinuation in radiotherapy for rectal cancer

Cancer Investigation

Volumn 28, Issue 3, 2010, Pages 289-294

  Lebwohl, Benjamin ^a   Ballas, Leslie ^a   Cao, Yin ^b   Chan, Galant ^a   Grossman, Reuven ^c   Sherr, David L ^c   Woodhouse, Shermian ^a   Neugut, Alfred I ^a,b  

^a Department of Medicine   (United States)

^b Department of Medicine   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Colorectal anal cancer; Outcomes research; Radiation oncology

Indexed keywords

CAPECITABINE; FLUOROURACIL; OXALIPLATIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DESQUAMATION; DIARRHEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CANCER; RISK FACTOR; TREATMENT DURATION; TREATMENT REFUSAL;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RECTAL NEOPLASMS; SEX CHARACTERISTICS;

EID: 77149171513     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900903476786     Document Type: Article

References (14)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M.J. Cancer statistics, 2008. CA Cancer J Clin 2008, 58, 71-96.
2. Nagy, V.M. Updating the management of rectal cancer. J Gastrointestin Liver Dis 2008, 17, 69-74.
3. Desch, C.E.; McNiff, K.K.; Schneider, E.C.; Schrag, D.; McClure, J.; Lepisto, E.; Donaldson, M.S.; Kahn, K.L.; Weeks, J.C.; Ko, C.Y.; Stewart, A.K.; Edge, S.B. American society of clinical oncology/national comprehensive cancer network quality measures. J Clin Oncol 2008, 26, 3631-3637.
4. Dobie, S.A.; Warren, J.L.; Matthews, B.; Schwartz, D.; Baldwin, L.M.; Billingsley, K. Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population. Cancer 2008, 112, 789-799.
5. Neugut, A.I.; Matasar, M.; Wang, X.; McBride, R.; Jacobson, J.S.; Tsai, W.Y.; Grann, V.R.; Hershman, D.L. Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol 2006, 24, 2368-2375.
6. Hershman, D.; McBride, R.; Jacobson, J.S.; Lamerato, L.; Roberts, K.; Grann, V.R.; Neugut, A.I. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 2005, 23, 6639-6646.
7. Gold, H.T.; Do, H.T.; Dick, A.W. Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer. Cancer 2008, 113, 3108-3115.
8. Weber, D.C.; Kurtz, J.M.; Allal, A.S. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 2001, 50, 675-680.
9. Videtic, G.M.; Fung, K.; Tomiak, A.T.; Stitt, L.W.; Dar, A.R.; Truong, P.T.; Yu, E.W.; Vincent, M.D.; Kocha, W.I. Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control. Lung Cancer 2001, 33, 249-258.
10. Kwong, D.L.; Sham, J.S.; Chua, D.T.; Choy, D.T.; Au, G.K.; Wu, P.M. The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1997, 39, 703-710.
11. Barton, M.B.; Keane, T.J.; Gadalla, T.; Maki, E. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother Oncol 1992, 23, 137-143.
12. Srokowski, T.P.; Fang, S.; Duan, Z.; Buchholz, T.A.; Hortobagyi, G.N.; Goodwin, J.S.; Giordano, S.H. Completion of adjuvant radiation therapy among women with breast cancer. Cancer 2008, 113, 22-29.
13. Bese, N.S.; Sut, P.A.; Sut, N.; Ober, A. The impact of treatment interruptions on locoregional control during postoperative breast irradiation. J BUON 2007, 12, 353-359.
14. Massie, M.J. Prevalence of depression in patients with cancer. J Nat Cancer Inst Monogr 2004, 32, 57-71.